Related Experiment Video
Updated: Feb 8, 2026
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Impact of Zinc Supplementation in Adults With Chronic Kidney Disease: A Systematic Review and Meta-Analysis of
Natalie L X Tan1, Maya Young2, Kelly Lambert1
1School of Medical, Indigenous and Health Sciences, University of Wollongong, New South Wales, Wollongong, Australia.
Context:
Zinc deficiency is prevalent in people with chronic kidney disease (CKD) and has significant clinical implications. Previous systematic reviews have only evaluated the impact of zinc supplementation on a limited range of biochemical outcomes in people receiving hemodialysis.
Objective:
In this analysis we sought to evaluate the impact of zinc supplementation on all outcomes in adults with CKD, including kidney replacement therapies.
Data Sources:
We conducted a systematic search across Cochrane, MEDLINE, CINAHL, PubMed, Scopus, and Google Scholar to identify randomized controlled trials assessing any outcomes in adults with CKD.
Data Extraction:
Three authors independently assessed trial eligibility, extracted data, and assessed the risk of bias using the Cochrane Risk of Bias Tool and the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology.
Data Analyses:
We identified 41 studies, with 23 included in meta-analyses. In total, 176 outcomes were reported, of which 11 were meta-analyzed. Zinc supplementation resulted in a significant increase in body weight (weighted mean difference [WMD], 2.52 kg; 95% CI, 1.58-3.45; P < .00001), serum zinc (WMD, 24.96 µg/dL; 95% CI, 20.43-29.50; P < .00001), high density lipoprotein cholesterol (HDL-C; WMD, 8.05 mg/dL; 95% CI, 0.22-15.88; P = .04), albumin (WMD, 0.38 g/dL; 95% CI, 0.07-0.69; P = .02), and dietary energy intake (WMD, 271.80 kcal; 95% CI, 172.70-370.90; P < .00001). No significant difference was observed in body mass index, total cholesterol, triglycerides, creatinine, and dietary protein and zinc intakes. Qualitative synthesis suggests that zinc supplementation may improve gastrointestinal symptoms, intensity of pruritus, quality of life, and quality of sleep.
Conclusions:
In patients with CKD, znc supplementation is associated with increases in body weight, serum zinc, high-density lipoprotein-cholesterol (HDL-C), albumin, and dietary energy intake. The current body of evidence is of low quality, highlighting the need for further high-quality research to substantiate these findings and for the translation of findings into clinical practice.
Systematic Review Registration:
PROSPERO registration no. CRD42024574253.
Related Concept Videos
01:20Random and Systematic Errors
01:25Chronic Kidney Disease I: Introduction
01:24Chronic Kidney Disease II: Clinical Manifestations
01:28Chronic Kidney Disease III: Interprofessional Care
01:18Chronic Kidney Disease IV: Nursing Management
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...